These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8398914)

  • 1. Neoadjuvant carboplatin and ifosfamide chemotherapy for inoperable FIGO stage III and IV ovarian carcinoma.
    Lim JT; Green JA
    Clin Oncol (R Coll Radiol); 1993; 5(4):198-202. PubMed ID: 8398914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of ifosfamide and cisplatinum in advanced ovarian cancer.
    Aziz Z; Zahid M; Ud Din Ahmed Z; Arshad T
    Aust N Z J Med; 1998 Jun; 28(3):403-9. PubMed ID: 9673759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised study of carboplatin vs sequential ifosfamide/carboplatin for patients with FIGO stage III epithelial ovarian carcinoma. The London Gynaecologic Oncology Group.
    Perren TJ; Wiltshaw E; Harper P; Slevin M; Stein R; Tan S; Gore M; Fryatt IJ; Blake PR
    Br J Cancer; 1993 Dec; 68(6):1190-4. PubMed ID: 8260372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer.
    Papadimitriou CA; Kouroussis C; Moulopoulos LA; Vlahos G; Rodolakis A; Kiamouris C; Diakomanolis E; Gika D; Michalas S; Dimopoulos MA
    Cancer; 2001 Oct; 92(7):1856-63. PubMed ID: 11745258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
    Margolin K; Doroshow JH; Ahn C; Hamasaki V; Leong L; Morgan R; Raschko J; Shibata S; Somlo G; Tetef M
    J Clin Oncol; 1996 Oct; 14(10):2631-7. PubMed ID: 8874321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness.
    da Costa Miranda V; de Souza Fêde ÂB; Dos Anjos CH; da Silva JR; Sanchez FB; da Silva Bessa LR; de Paula Carvalho J; Filho EA; de Freitas D; Del Pilar Estevez Diz M
    Gynecol Oncol; 2014 Feb; 132(2):287-91. PubMed ID: 24333355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboplatin, etoposide, and ifosfamide as second-line treatment for ovarian cancer.
    Fanning J; Hilgers RD; Hutson E
    Am J Clin Oncol; 1994 Aug; 17(4):335-7. PubMed ID: 8048396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-line treatment with ifosfamide and carboplatin in patients with ovarian carcinoma relapsing after treatment with carboplatin.
    Dobbs SP; Gribbin C; Chan SY; Bessell EM
    Eur J Cancer; 1994; 30A(1):30-3. PubMed ID: 7511401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study.
    Ansquer Y; Leblanc E; Clough K; Morice P; Dauplat J; Mathevet P; Lhommé C; Scherer C; Tigaud JD; Benchaib M; Fourme E; Castaigne D; Querleu D; Dargent D
    Cancer; 2001 Jun; 91(12):2329-34. PubMed ID: 11413522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy of intraperitoneal carboplatin and intravenous paclitaxel in suboptimally debulked epithelial ovarian cancer.
    Nagao S; Fujiwara K; Ohishi R; Nakanishi Y; Iwasa N; Shimizu M; Goto T; Shimoya K
    Int J Gynecol Cancer; 2008; 18(6):1210-4. PubMed ID: 18284454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy for advanced ovarian cancer.
    Schwartz PE; Chambers JT; Makuch R
    Gynecol Oncol; 1994 Apr; 53(1):33-7. PubMed ID: 8175019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
    Sutton GP; Blessing JA; Photopulos G; Berman ML; Homesley HD
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):68-72. PubMed ID: 2539647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neo-adjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer treatment--a retrospective study].
    Tkácová M; Vertaková-Krakovská B; Belohorská B; Miskovská V; Helpianska L; Ondrus D; Ondrusová M; Spánik S; Svec J
    Klin Onkol; 2009; 22(6):273-7. PubMed ID: 20099745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube, or primary peritoneal carcinomas.
    Ebata T; Yunokawa M; Bun S; Shimomura A; Shimoi T; Kodaira M; Yonemori K; Shimizu C; Fujiwara Y; Kato T; Tamura K
    Cancer Chemother Pharmacol; 2016 Dec; 78(6):1283-1288. PubMed ID: 27832327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinosarcoma of the ovary.
    Silasi DA; Illuzzi JL; Kelly MG; Rutherford TJ; Mor G; Azodi M; Schwartz PE
    Int J Gynecol Cancer; 2008; 18(1):22-9. PubMed ID: 17451459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tandem high-dose chemotherapy with ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinoma.
    Lotz JP; Bouleuc C; André T; Touboul E; Macovei C; Hannoun L; Lefranc JP; Houry S; Uzan S; Izrael V
    Cancer; 1996 Jun; 77(12):2550-9. PubMed ID: 8640705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined high-dose carboplatin and cisplatin, and ifosfamide in previously untreated ovarian cancer patients with residual disease.
    Lund B; Hansen M; Hansen OP; Hansen HH
    J Clin Oncol; 1990 Jul; 8(7):1226-30. PubMed ID: 2113570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of carboplatin versus iproplatin in untreated advanced ovarian cancer.
    Trask C; Silverstone A; Ash CM; Earl H; Irwin C; Bakker A; Tobias JS; Souhami RL
    J Clin Oncol; 1991 Jul; 9(7):1131-7. PubMed ID: 2045855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer.
    Scagliotti GV; Ricardi U; Crinó L; Maranzano E; De Marinis F; Morandi MG; Meacci L; Marangolo M; Emiliani E; Rosti G; Figoli F; Bolzicco G; Masiero P; Gentile A; Tonato M
    Cancer Chemother Pharmacol; 1996; 38(6):561-5. PubMed ID: 8823499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study.
    Bell J; Brady MF; Young RC; Lage J; Walker JL; Look KY; Rose GS; Spirtos NM;
    Gynecol Oncol; 2006 Sep; 102(3):432-9. PubMed ID: 16860852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.